Overview Glyburide/Metformin 5 mg/500 mg Film-Coated Tablets, Fasting Status: Completed Trial end date: 2003-04-01 Target enrollment: Participant gender: Summary The objective of this study is to compare the rate and extent of absorption of Glyburide/Metformin 5 mg/500 mg film-coated tablets (test) versus Glucovance® (reference) administered as 1 x 5 mg/500 mg film-coated tablet under fasting conditions. Phase: Phase 1 Details Lead Sponsor: Teva Pharmaceuticals USATreatments: GlyburideMetformin